U.S. Supreme Court to Hear Oral Arguments Involving the FDA and Mifepristone
WASHINGTON — Today, the U.S. Supreme Court announced that it will hear arguments this term regarding the Food and Drug Administration’s decisions in 2016 and 2021 to loosen regulations of the abortion drug mifepristone and whether the challengers have standing to bring their case. ‘Today’s decision means the Court will hear about the dangers of […]
U.S. Supreme Court to Hear Oral Arguments Involving the FDA and Mifepristone Read More »